Amrize, Completes

Amrize Completes $1 Billion Buyback as Roofing Drag Clouds 2026 Guidance Cut

Published on 10/30/2026 at 15:21 | Editorial boerse-global.de
Amrize finished a $1 billion buyback covering about 4% of shares, but cut its 2026 revenue and EBITDA outlook as Building Envelope margins fell.
Amrize Completes $1 Billion Buyback as Roofing Drag Clouds 2026 Guidance Cut Illustration mit AI erstellt.

Amrize has wrapped up a $1 billion share repurchase programme covering roughly 4% of its share capital, closing the book on a capital-return drive that ran alongside a quarter of mixed operating signals. The buyback is finished — the shares have already been purchased, and media reports indicate they are to be cancelled — so the debate among investors now turns to how earnings and financial headroom develop once the distribution is behind the company.

Add the dividend and the total returned to shareholders through the third quarter reaches $1.1 billion. A quarterly payout of $0.11 per share is scheduled for 18 November.

Balance sheet holds up after the distribution

Leverage stood at 1.8 times trailing twelve-month EBITDA as of 30 September, with available liquidity of $3.4 billion. Capital expenditure in the third quarter came to $262 million. Those figures frame the question that matters more than the buyback itself: whether Amrize can keep funding returns while its operating performance evens out.

Prices offset softer volumes — with one exception

Net income for the quarter reached $558 million. Diluted earnings per share rose 4.1% to $1.02, and adjusted EBITDA of $1.1 billion came in slightly above the prior-year level. Price increases for cement and transport-cost surcharges offset cost inflation, and together with acquisitions, pricing compensated for weather-related volume declines.

Should investors sell immediately? Or is it worth buying Amrize?

The picture diverges sharply by segment. Building Materials leaned on firm pricing to widen its margin despite lower deliveries — aggregates prices climbed 6.9% and cement prices 1.8%, lifting the segment margin by 30 basis points. Morningstar's assessment published today likewise singles out the resilient pricing in that business.

Building Envelope tells the opposite story. Segment revenue rose 3.6% to $929 million, yet EBITDA fell 14.6%. Amrize does not expect a positive balance between pricing and costs in roofing until 2027, which leaves the segment without the relief that is propping up the rest of the group.

Guidance trimmed, and the earnings line took the deeper cut

For 2026, Amrize projects revenue of $12.2–12.4 billion and EBITDA of $2.95–3.05 billion. Both figures represent a reduction, and the composition of the cut carries its own message: according to Morningstar, the midpoint of the revenue range drops 2.4%, while the midpoint of the earnings forecast falls 4.8%. The steeper correction on the bottom line suggests the company cannot simply price its way out of the pressure.

The third quarter itself offered a counterweight. Revenue came in at $3.77 billion with adjusted earnings per share of $1.05, according to Morningstar's analysis — hardly the stuff of a blanket crisis verdict. A solid quarter and a weaker outlook can coexist.

ASPIRE savings ahead of schedule

Cost discipline is providing part of the buffer. The ASPIRE efficiency programme has delivered $73 million in savings since the start of the year against a full-year 2026 target of $80 million — a substantial share of the goal already banked. That counts as a positive execution signal, though it is no substitute for a recovery in the troubled roofing business.

Amrize at a turning point? This analysis reveals what investors need to know now.

What the share price move does and does not say

The stock gained 10% yesterday, a reaction that should not be read as confirmation that an operating turnaround has taken hold. Nor do the capital returns answer the central operating question: how durable earnings become if the roofing recovery takes longer than expected. A completed buyback neither improves the price-cost trajectory nor restores the trimmed annual targets.

Two developments therefore sit side by side for investors. The billion-dollar repurchase is done, and the operational improvement remains unevenly distributed. The next test for Amrize is whether Building Envelope stabilises — the company has to make its case through the business, not through the scale of its shareholder payouts.

Ad

Amrize Stock: New Analysis - 30 October

Fresh Amrize information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Amrize analysis...

Disclaimer...
en | CH1430134226 | AMRIZE | boerse | 70435169 |